Treatment of Acute Leukemia–Advances in Chemotherapy, Immunotherapy, and Bone Marrow Transplantation
- 1 January 1983
- book chapter
- Published by Elsevier in Advances in Cancer Research
- Vol. 40, 255-329
- https://doi.org/10.1016/s0065-230x(08)60682-x
Abstract
No abstract availableThis publication has 217 references indexed in Scilit:
- Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemiaCancer Letters, 1980
- Acute lymphoblastic leukaemia in adults: Clinicopathological correlations with the French-American-British (FAB) co-operative group classificationPublished by Elsevier ,1979
- Plasma levels and biotransformation of infused daunorubicin and daunorubicin-DNA complex in rabbits: A preliminary reportPublished by Elsevier ,1977
- HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1977
- The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) seriesPublished by Elsevier ,1974
- Experimental leukemia chemotherapy with a “lysosomotropic” adriamycin-DNA complexPublished by Elsevier ,1974
- Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumorsPublished by Elsevier ,1973
- 4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of actionPublished by Elsevier ,1970
- Predinsome therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patientsThe Journal of Pediatrics, 1967
- The effect of transfusions and antibiotics upon the duration of life in children with lymphogenous leucemiaThe Journal of Pediatrics, 1950